Focus
zepbound
Eli Lilly to Sell Weight Loss Drugs Directly to Patients
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
|
Stopping Treatment With Popular New Weight-Loss Drug May Lead to Regained Weight
However, about 17 percent of individuals prescribed a placebo kept about 80 percent of their original weight loss, a new trial shows.
|
FDA Approves Mounjaro as New Obesity Drug Zepbound
The decision will makes it easier for insurance coverage for millions struggling with excess weight.
|
Eli Lilly to Sell Weight Loss Drugs Directly to Patients
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
|
Stopping Treatment With Popular New Weight-Loss Drug May Lead to Regained Weight
However, about 17 percent of individuals prescribed a placebo kept about 80 percent of their original weight loss, a new trial shows.
|
FDA Approves Mounjaro as New Obesity Drug Zepbound
The decision will makes it easier for insurance coverage for millions struggling with excess weight.
|